Botulinum Toxin Type A for Foot Dystonia-associated Pain in Parkinson's Disease

NCT04277247 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Calgary

Collaborators